Imaging of lymph node metastases in cervical cancer

Bernardini, Marcus Q.; Covens, Allan
March 2008
CMAJ: Canadian Medical Association Journal;3/25/2008, Vol. 178 Issue 7, p867
Academic Journal
The article discusses the imaging of lymph node metastases in cervical cancer patients. According to the authors, the application of imaging methods such as magnetic resonance imaging, computed tomography and positron emission tomography in determining lymph node status will require positive ratios in early cases of cervical cancer and negative ratios in advanced cervical cancer to alter clinical management. Researches which address the role of imaging in advanced cervical cancer and focus on identifying the extent of the disease are also mentioned.


Related Articles

  • DETECTING METASTATIC CANCER LESIONS... Before it is Too Late! Goepp, Julius // Life Extension;Mar2009, Vol. 15 Issue 3, p50 

    The article focuses on the effectiveness of Combidex, a diagnostic procedure that uses magnetic resonance imaging for metastasis. It states that Combidex is more effective than more invasive surgical processes for revealing small and undetectable lymph node metastases in patients with cancer....

  • Imaging for Staging Cervical Cancer. Vasko, C. // Medical Imaging;Dec2007, Vol. 22 Issue 12, p14 

    The article presents results of a study on the efficiency of the combined fluorodeoxyglucose(FDG)-enhanced position emission tomography (PET)/computed tomography(CT) and Combidex magnetic resonance imaging (MRI) to detect cancers, issued by the American College of Radiology Imaging Network and...

  • Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer. Harisinghani, Mukesh G.; Barentsz, Jelle; Hahn, Peter F.; Deserno, Willem M.; Tabatabaei, Shahin; van de Kaa, Christine Hulsbergen; de la Rosette, Jean; Weissleder, Ralph // New England Journal of Medicine;6/19/2003, Vol. 348 Issue 25, p2491 

    Background: Accurate detection of lymph-node metastases in prostate cancer is an essential component of the approach to treatment. We investigated whether highly lymphotropic superparamagnetic nanoparticles, which gain access to lymph nodes by means of interstitial–lymphatic fluid...

  • Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer. Schmidt, G. P.; Baur-Melnyk, A.; Haug, A.; Utzschneider, S.; Becker, C. R.; Tiling, R.; Reiser, M. F.; Hermann, K. A. // European Radiology;Jun2009, Vol. 19 Issue 6, p1366 

    The purpose of this study was to assess the diagnostic accuracy of whole-body MRI (WB-MRI) at 1.5 T or 3 T compared with FDG-PET-CT in the follow-up of patients suffering from colorectal cancer. In a retrospective study, 24 patients with a history of colorectal cancer and suspected tumour...

  • PET/CT underestimated lymph node staging in breast cancer. Hudis, Clifford A. // Hem/Onc Today;10/10/2008, Vol. 9 Issue 18, p24 

    The discusses research which showed that positron emission tomography/computed tomography (PET/CT) scanning was not able to replace lymphadenectomy for locoregional lymph node staging in patients with large primary breast tumors, but may be valuable in detecting distant metastases. It references...

  • Diffusion-weighted MR imaging in primary rectal cancer staging demonstrates but does not characterise lymph nodes. Heijnen, Luc A.; Lambregts, Doenja M. J.; Mondal, Dipanjali; Martens, Milou H.; Riedl, Robert G.; Beets, Geerard L.; Beets-Tan, Regina G. H. // European Radiology;Dec2013, Vol. 23 Issue 12, p3354 

    Objectives: To evaluate the performance of diffusion-weighted MRI (DWI) for the detection of lymph nodes and for differentiating between benign and metastatic nodes during primary rectal cancer staging. Methods: Twenty-one patients underwent 1.5-T MRI followed by surgery (± preoperative...

  • Detection of Lymph Node Metastases by Gadolinium-Enhanced Magnetic Resonance Imaging: Systematic Review and Meta-analysis. Klerkx, Wenche M.; Bax, Leon; Veldhuis, Wouter B.; Heintz, A. Peter M.; Mali, Willem PThM.; Peeters, Petra H. M.; Moons, Karel G. M. // JNCI: Journal of the National Cancer Institute;2/24/2010, Vol. 102 Issue 4, p244 

    Background: Gadolinium-based contrast agents are used with magnetic resonance imaging (MRI) to highlight tumor vascularity in organs. They are also widely used for primary tumor visualization. We conducted a systematic review and meta-analysis of the existing evidence of the accuracy of...

  • Diffusion-weighted MRI may help detect lymph node metastases.  // Urology Times;Jan2012, Vol. 40 Issue 1, p42 

    The article reports on a study presented at the annual meeting of the Radiological Society of North America in 2011 in Chigaco regarding the use of diffusion-weight magnetic resonance imaging (MRI) in detecting pelvic node metastases in lymp nodes.

  • Computed tomography, magnetic resonance imaging and FDG positron emission tomography in the management of vulvar malignancies. Lin, Gigin; Chen, Chao-Yu; Liu, Feng-Yuan; Yang, Lan-Yan; Huang, Huei-Jean; Huang, Yi-Ting; Jung, Shih-Ming; Chou, Hung-Hsueh; Lai, Chyong-Huey; Ng, Koon-Kwan // European Radiology;May2015, Vol. 25 Issue 5, p1267 

    Objectives: To prospectively evaluate the value of CT or MRI (CT/MRI) and PET in the management of vulvar malignancies. Methods: Abdominal and pelvic CT/MRI and whole-body F-FDG (fluorodeoxyglucose) PET or PET/CT (collectively designated PET hereafter) were performed. Lesion status was...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics